Liraglutide Improves Non-Motor Function and Activities of Daily Living in Patients with Parkinson’s disease: A Randomized, Double-Blind, Placebo-Controlled Trial (P9-11.005) | Synapse
May 3, 2022
Liraglutide Improves Non-Motor Function and Activities of Daily Living in Patients with Parkinson’s disease: A Randomized, Double-Blind, Placebo-Controlled Trial (P9-11.005)
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
To test the therapeutic efficacy and safety of the GLP-1 agonist liraglutide in patients with idiopathic PD.